Does the FDA’s future under Trump 2.0 mean innovation or instability? | Opinion
The founding director of the FDA’s Office of Biotechnology writes that, with FDA approval of medications ultimately vested ...
Newsweek26d
Trump Administration's Cuts to FDA Employees Raises Concerns
The FDA has also come under fire for slow responses to safety concerns, including contamination issues in baby food, infant formula shortages, and tainted eye drops. Kevin Thompson, a finance ...
Trump’s FDA nominee grilled on vaccine meeting, agency staffing
Marty Makary, Trump’s pick for FDA commissioner, testified before the Senate health committee Thursday.
Kennedy asks FDA to revise 'self-affirm' rule for food ingredient safety
U.S. Secretary of Health and Human Services Robert Kennedy Jr. directed the Food and Drug Administration on Monday to revise ...
CBS News22d
Top FDA food safety official's resignation letter warns firings will backfire on RFK Jr.
Jones had come into his role at the FDA as part ... for use in food should still be considered safe. Under the program, the FDA moved to ban the color additive Red 3 for causing cancer in some ...
Salon2d
RFK Jr. wants to completely remove the FDA's food additive program as part of MAHA campaign
The latest initiative comes after the FDA proposed a new requirement in January to include nutrition labels on the front of packaged foods and drinks. Called the “Nutrition Info box,” the ...
New York Post9d
FDA recalls common Chinese food ingredient after undeclared sulfites found in Florida inspection
A California company’s dried lily flowers have been recalled because they may contain undeclared sulfites, according to the U.S. Food and Drug Administration. The FDA and Hayward, California ...
MedPage Today25d
FDA Layoffs in Staff Overseeing Food Safety, Medical Devices, and Tobacco Products
Nearly half of the FDA's $6.9 billion budget comes from fees paid by companies ... a former FDA associate commissioner under President George W. Bush. "You want people with new ideas, greater ...
Benzinga.com10d
Capricor Therapeutics Cell Therapy Goes Under Priority FDA Review For Duchenne Associated-Heart Condition
FDA sets an August 31, 2025, action date for Capricor’s deramiocel BLA review. Capricor may receive a Priority Review Voucher if approval comes by September 2026. Our government trade tracker ...